Jenny Sundqvist
Chief Executive Officer bij INDEX PHARMACEUTICALS HOLDING AB
Profiel
Jenny Sundqvist is currently the Chief Executive Officer at InDex Pharmaceuticals Holding AB since 2023.
Previously, she worked as the Chief Commercial Officer at Isofol Medical AB.
She completed her undergraduate degree at Louisiana State University and earned an MBA from McCombs School of Business.
Actieve functies van Jenny Sundqvist
| Bedrijven | Functie | Begin |
|---|---|---|
| INDEX PHARMACEUTICALS HOLDING AB | Chief Executive Officer | 01-01-2023 |
Eerdere bekende functies van Jenny Sundqvist
| Bedrijven | Functie | Einde |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01-04-2021 |
| ISOFOL MEDICAL AB | Corporate Officer/Principal | - |
Opleiding van Jenny Sundqvist
| Louisiana State University | Undergraduate Degree |
| McCombs School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| INDEX PHARMACEUTICALS HOLDING AB | Health Technology |
| ISOFOL MEDICAL AB | Health Technology |
